COST-EFFECTIVENESS OF FERRIC CARBOXYMALTOSE IN THE TREATMENT OF IRON-DEFICIENCY ANEMIA IN PREGNANT WOMEN

被引：0
|
作者：
Alves, Junior J. M. [1 ]
Prota, F. E. [1 ]
Martinelli, J. C. B. [1 ]
Chrispim, A. [1 ]
Christoforo, F. F. [1 ]
Serpeloni, M. [2 ]
Barreto, I [3 ]
da Silva, A. C. [3 ]
机构：
[1] Unimed Campinas, Campinas, Brazil
[2] Unimed Campinas, Nova Odessa, SP, Brazil
[3] Unimed Campinas, Campinas, SP, Brazil
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE256
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [21] Efficacy and Cost Effectiveness of Intravenous Ferric Carboxymaltose Versus Iron Sucrose in Adult Patients with Iron Deficiency Anemia
    Basha, Ahmed
    Izham, Mohamed
    Hamad, Anas
    Chandra, Prem
    Omar, Nabil E.
    Abdulla, Mohammad Abdul-Jaber
    Aldapt, Mahmood B.
    Hussein, Radwa M.
    Mahfouz, Ahmed
    Adel, Ahmed A.
    Shwaylia, Hawraa M.
    Ekeibed, Yeslem Mohamed Aly
    AbuMousa, Rami
    Yassin, Mohamed A.
    BLOOD, 2020, 136
  • [22] Ferric carboxymaltose for patients with heart failure and iron deficiency in Italy: cost-effectiveness and budget impact
    Rognoni, Carla
    Gerzeli, Simone
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (13) : 1099 - 1110
  • [23] A Cost-effectiveness Analysis of Ferric Carboxymaltose in Patients With Iron Deficiency and Chronic Heart Failure in Spain
    Comin-Colet, Josep
    Rubio-Rodriguez, Dario
    Rubio-Terres, Carlos
    Enjuanes-Grau, Cristina
    Gutzwiller, Florian S.
    Anker, Stefan D.
    Ponikowski, Piotr
    REVISTA ESPANOLA DE CARDIOLOGIA, 2015, 68 (10): : 846 - 851
  • [24] Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Ferric Carboxymaltose in Chinese Patients with Iron-deficiency Anemia
    Ding, Yanhua
    Zhu, Xiaoxue
    Li, Xiaojiao
    Zhang, Hong
    Wu, Min
    Liu, Jingrui
    Palmen, Mary
    Roubert, Bernard
    Li, Cuiyun
    CLINICAL THERAPEUTICS, 2020, 42 (02) : 276 - 285
  • [25] Effects of ferric carboxymaltose on phosphate and calcium homeostasis in a murine model of iron-deficiency anemia
    Stevens, Monica
    Thomas, Linto
    Rieg, Timo
    Rieg, Jessica Dominguez
    FASEB JOURNAL, 2022, 36
  • [26] The use of ferric carboxymaltose infusions on the same day as endoscopy in the management of iron-deficiency anemia
    Bloom, A.
    Be, K.
    Trakarnwijitr, I.
    Varma, P.
    Pianko, S.
    Swan, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 18 - 19
  • [27] Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost-effectiveness analysis utilising AFFIRM-AHF
    McEwan, Phil
    Ponikowski, Piotr
    Davis, Jason A.
    Rosano, Giuseppe
    Coats, Andrew J. S.
    Dorigotti, Fabio
    O'Sullivan, Donal
    de Arellano, Antonio Ramirez
    Jankowska, Ewa A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (10) : 1687 - 1697
  • [28] Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia: Letter to Editor
    Kanshaiym, Sakiyeva
    Zhurabekova, Gulmira
    Abdelazim, Ibrahim A.
    Starchenko, Tatyana
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2020, 42 (01) : 98 - 99
  • [29] Ferric carboxymaltose for treatment of iron deficiency and iron deficiency anemia caused by abnormal uterine bleeding
    Hagras, Ahmed M.
    Hussein, Naglaa Ali
    Abdelazim, Ibrahim
    Elhamamy, Nareman
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2022, 21 (04): : 223 - 228
  • [30] Cost-utility of ferric carboxymaltose (Ferinject®) for iron-deficiency anemia patients with chronic heart failure in South Korea
    Eun-A Lim
    Hyun-Soon Sohn
    Haeyoung Lee
    Sang-Eun Choi
    Cost Effectiveness and Resource Allocation, 12
12345